Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF

Journal of Neuroimmunology

Volumn 233, Issue 1-2, 2011, Pages 192-203

  Yu, Xiaoli ^a   Gilden, Don ^a,b   Schambers, Laura ^a   Barmina, Olga ^a   Burgoon, Mark ^a   Bennett, Jeffrey ^a,b   Owens, Greg ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Epitope; Mimotope; Multiple sclerosis; Random peptide library

Indexed keywords

IMMUNOGLOBULIN G; RECOMBINANT ANTIBODY;

ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CASE REPORT; CEREBROSPINAL FLUID; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PHAGE DISPLAY; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AUTOANTIBODIES; CLONE CELLS; HUMANS; IMMUNOGLOBULIN G; MULTIPLE SCLEROSIS; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PLASMA CELLS; RECOMBINANT PROTEINS;

EID: 79953307229     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.11.007     Document Type: Article

References (40)

1. Aloisi F., Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 2006, 6:205-217.
2. Archelos J.J., Trotter J., Previtali S., Weissbrich B., Toyka K.V., Hartung H.P. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis. Ann. Neurol. 1998, 43:15-24.
3. Bennett J.L., Lam C., Kalluri S.R., Saikali P., Bautista K., DuPree C., Glogowska M., Case D., Antel J.P., Owens G.P., Gilden D., Nessler S., Stadelmann C., Hemmer B. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann. Neurol. 2009, 66:617-629.
4. Berger T., Rubner P., Schautzer F., et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N. Engl. J. Med. 2003, 349:139-145.
5. Burgoon M.P., Keays K.M., Owens G.P., Ritchie A.M., Rai P.R., Cool C.D., Gilden D.H. Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7245-7250.
6. Cortese I., Tafi R., Grimaldi L.M., Martino G., Nicosia A., Cortese R. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:11063-11067.
7. Cortese I., Capone S., Tafi R., Grimaldi L.M., Nicosia A., Cortese R. Identification of peptides binding to IgG in the CSF of multiple sclerosis patients. Mult. Scler. 1998, 4:31-36.
8. Cortese I., Capone S., Luchetti S., Cortese R., Nicosia A. Cross-reactive phage-displayed mimotopes lead to the discovery of mimicry between HSV-1 and a brain-specific protein. J. Neuroimmunol. 2001, 113:119-128.
9. Fraussen J., Vrolix K., Martinez-Martinez P., Losen M., De Baets M.H., Stinissen P., Somers V. B cell characterization and reactivity analysis in multiple sclerosis. Autoimmun. Rev. 2009, 8:654-658.
10. Genain C., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 1999, 5:170-175.
11. Gilden D.H. Infectious causes of multiple sclerosis. Lancet Neurol. 2005, 4:195-202.
12. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688.
13. Kuhle J., Pohl C., Mehling M., et al. Lack of association between antimyelin antibodies and progression to multiple sclerosis. N. Engl. J. Med. 2007, 356:371-378.
14. Lalive P.H., Mengue T., Delarasse C., et al. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc. Natl Acad. Sci. USA 2006, 103:2280-2285.
15. Lambracht-Washington D., O'Connor K.C., Jowdry A., et al. Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. J. Neuroimmunol. 2007, 186:164-176.
16. Lampasona V., Franciotta D., Furlan R., et al. Similar low frequency of anti-MOG and IgM in MS patients and healthy subjects. Neurology 2004, 62:2092-2094.
17. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., Reynolds R., Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130:1089-1104.
18. McLaughlin K.A., Wucherpfennig K.W. B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv. Immunol. 2008, 98:121-149.
19. Monson N.L., Brezinschek H.P., Brezinschek R.I., Mobley A., Vaughan G.K., Frohman E.M., Racke M.K., Lipsky P.E. Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients. J. Neuroimmunol. 2005, 158:170-181.
20. O'Connor K.C., Chitnis T., Griffin D.E., et al. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by lowaffinity interactions. J. Neuroimmunol. 2003, 136:140-148.
21. O'Connor K.C., McLaughlin K.A., DeJager P.L., et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat. Med. 2007, 13:211-217.
22. Obermeier B., Mentele R., Malotka J., Kellermann J., Kumpfel T., Wekerle H., Lottspeich F., Hohlfeld R., Dornmair K. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat. Med. 2008, 14:688-693.
23. Owens G.P., Kraus H., Burgoon M.P., Smith-Jensen T., Devlin M.E., Gilden D.H. Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann. Neurol. 1998, 43:236-243.
24. Owens G.P., Ritchie A.M., Burgoon M.P., Williamson R.A., Corboy J.R., Gilden D.H. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J. Immunol. 2003, 171:2725-2733.
25. Owens G.P., Shearer A.J., Yu X., Ritchie A.M., Keays K.M., Bennett J.L., Gilden D.H., Burgoon M.P. Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein. J. Virol. 2006, 80:12121-12130.
26. Owens G.P., Bennett J.L., Lassmann H., O'Connor K.C., Ritchie A.M., Shearer A., Lam C., Yu X., Birlea M., DuPree C., Williamson R.A., Hafler D.A., Burgoon M.P., Gilden D. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann. Neurol. 2009, 65:639-649.
27. Reindl M., Linington C., Brehm U., et al. Antibodies against the myelin oligodendrocyte glycoprotein and myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 1999, 22:2047-2056.
28. Ritchie A.M., Gilden D.H., Williamson R.A., Burgoon M.P., Yu X., Helm K., Corboy J.R., Owens G.P. Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis. J. Immunol. 2004, 173:649-656.
29. Scott J.K., Smith G.P. Searching for peptide ligands with an epitope library. Science 1990, 249:386-390.
30. Villar L.M., Sadaba M.C., Roldan E., Masjuan J., Gonzalez-Porque P., Villarrubia N., Espino M., Garcia-Trujillo J.A., Bootello A., Alvarez-Cermeno J.C. Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. J. Clin. Invest. 2005, 115:187-194.
31. von Budingen H.C., Gulati M., Kuenzle S., Fischer K., Rupprecht T., Goebels N. Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands". J. Neuroimmunol. 2010, 218:134-139.
32. von Büdingen H.C., Harrer M.D., Kuenzle S., et al. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies. Eur. J. Immunol. 2008, 38:2014-2023.
33. Winges K.M., Gilden D.H., Bennett J.L., Yu X., Ritchie A.M., Owens G.P. Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts. J. Neuroimmunol. 2007, 192:226-234.
34. Yu X., Gilden D.H., Ritchie A.M., Burgoon M.P., Keays K.M., Owens G.P. Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library. J. Neuroimmunol. 2006, 172:121-131.
35. Yu X., Owens G.P., Gilden D.H. Rapid and efficient identification of epitopes/mimotopes from random peptide libraries. J. Immunol. Methods 2006, 316:67-74.
36. Yu X., Burgoon M.P., Shearer A.J., Gilden D.H. Characterization of phage peptide interaction with antibody using phage mediated immuno-PCR. J. Immunol. Methods 2007, 326:33-40.
37. Yu X., Barmina O., Burgoon M., Gilden D. Identification of measles virus epitopes using an ultra-fast method of panning phage-displayed random peptide libraries. J. Virol. Methods 2009, 156:169-173.
38. Zhang Y., Da R.R., Guo W., Ren H.M., Hilgenberg L.G., Sobel R.A., Tourtellotte W.W., Smith M.A., Olek M., Gupta S., Robertson R.T., Nagra R., Van Den Noort S., Qin Y. Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis. J. Clin. Immunol. 2005, 25:254-264.
39. Zhang Y., Da R.R., Hilgenberg L.G., Tourtellotte W.W., Sobel R.A., Smith M.A., Olek M., Nagra R., Sudhir G., van den Noort S., Qin Y. Clonal expansion of IgA positive plasma cells and axon-reactive antibodies in MS lesions. J. Neuroimmunol. 2005, 167:120-130.
40. Zhou D., Srivastava R., Nessler S., et al. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl Acad. Sci. USA 2006, 103:19057-19062.